Illinois CancerCare is committed to advancing cancer treatment forward through clinical trials. Research offers our patients access to national clinical trials and cutting-edge treatment options close to home. Illinois CancerCare is recognized among the top community research centers in the nation. Our goal is to provide the most advanced cancer treatments possible in settings close to home where patients can be surrounded by family and friends. The newest and most promising treatments are often available only through clinical research trials. Participation in clinical trials can benefit not only you, but future cancer patients as well. Over 10,000 Illinois CancerCare patients have participated in such trials.
Following is a listing of clinical trials currently available at Illinois CancerCare. If you would like more information about a clinical trial, please contact of our research team at 309-243-3605.
Neoadjuvant – therapy given before the primary treatment (generally surgery)
Adjuvant – therapy following the primary treatment (generally surgery)
Metastatic – therapy given for cancer that has traveled from its origin to another part of the body
1st line – the first treatment regimen given for a disease
2nd line – the second treatment regimen given following failure or discontinuation of the first treatment regimen.
Relapsed – the return of disease after a period of remission
Refractory – disease that has not adequately responded to treatment